Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

Cancer immunotherapy has shown remarkable clinical progress in recent years. Although age is one of the biggest leading risk factors for cancer development and older adults represent a majority of cancer patients, only a few new cancer immunotherapeutic interventions have been preclinically tested i...

Descripción completa

Detalles Bibliográficos
Autores principales: Uher, Ondrej, Hadrava Vanova, Katerina, Lencova, Radka, Frejlachova, Andrea, Wang, Herui, Zhuang, Zhengping, Zenka, Jan, Pacak, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277857/
https://www.ncbi.nlm.nih.gov/pubmed/37342258
http://dx.doi.org/10.3389/fendo.2023.1030412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277857/
https://www.ncbi.nlm.nih.gov/pubmed/37342258
http://dx.doi.org/10.3389/fendo.2023.1030412

Ejemplares similares